Form Type: 4

SEC EDGAR Link
Accession Number:0001061983-20-000065
Date:2020-03-06
Issuer: CYTOKINETICS INC (CYTK)
Original Submission Date:

Reporting Person:

WONG ROBERT
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-03-06 A 10,000 a $0.00 13,004 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
INCENTIVE STOCK OPTION (RIGHT TO BUY) 14.4 2020-03-06 deemed execution date A 5,590 (a) 2030-03-05 common stock 5,590 $14.40 5,590 direct
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 14.4 2020-03-06 deemed execution date A 14,410 (a) 2030-03-05 common stock 14,410 $14.40 14,410 direct
Footnotes
IDfootnote
f1 includes up to 3004 shares of common stock purchased pursuant to the cytokinetics, incorporated employee stock purchase plan.
f2 this option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.
WhaleWisdom Logo

Elevate your investments